Equities

Guangzhou Jet Bio-Filtration Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Guangzhou Jet Bio-Filtration Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)18.40
  • Today's Change0.07 / 0.38%
  • Shares traded1.56m
  • 1 Year change+37.31%
  • Beta1.3379
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Guangzhou Jet Bio-Filtration Co Ltd is a China-based company principally engaged in the research, development, production and sales of cell culture and related liquid handling life science consumables. The Company's main products include two categories of life science consumables, biological culture and liquid handling, as well as a small number of biological reagents, small laboratory instruments, protective equipment, medical devices and others. The Company's products are used in fields such as biomedicine, molecular diagnosis, medical protection, cell therapy, and biological research. The Company distributes its products within the domestic market and to overseas markets.

  • Revenue in CNY (TTM)566.02m
  • Net income in CNY79.32m
  • Incorporated2001
  • Employees1.08k
  • Location
    Guangzhou Jet Bio-Filtration Co LtdNo.1 Doutang Road, Yonghe Economic ZoneEconomic and Technological Development ZGUANGZHOU 511356ChinaCHN
  • Phone+86 2 032811868
  • Fax+86 2 032811888
  • Websitehttps://www.jetbiofil.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Suzhou Iron Technology Co Ltd381.50m5.23m1.96bn680.00321.512.52--5.140.0790.0795.1010.060.28222.231.50--0.43664.750.71547.3443.1053.911.5514.711.201.290.213331.78-10.522.22-173.52------
Shanghai Rendu Biotechnology Co Ltd165.86m-5.47m2.09bn335.00--2.28--12.61-0.1374-0.13744.1422.920.16621.622.93495,112.60-0.54824.37-0.58754.9176.4673.71-3.3012.6113.50--0.004711.167.8712.33-194.59---28.11--
Guangzhou Jet Bio-Filtration Co Ltd566.02m79.32m2.57bn1.08k34.152.08--4.550.53670.53673.758.810.3352.654.37523,125.404.817.565.108.3341.0736.8514.3516.266.469.350.233421.0320.6317.68107.511.7614.94-27.21
Guangzhou LBP Medicine Scnc&Tech Co Ltd371.03m-19.11m2.60bn796.00--2.12--7.01-0.2042-0.20423.9713.100.27611.551.71466,121.80-1.493.50-1.553.7863.0372.02-5.419.797.80--0.011832.69-5.335.80-46.85-22.05-7.83--
Maider Medical Industry Equipment Co Ltd279.92m-18.77m2.78bn657.00--3.46--9.95-0.1053-0.10531.684.850.2491.072.08426,058.40-3.345.79-4.306.8634.6849.32-13.4016.231.91--0.070563.92-42.775.58-120.02--22.08--
Jiangsu Cowin Biotech Co Ltd167.17m-137.72m2.89bn833.00--2.08--17.31-1.24-1.241.5112.360.10381.812.52200,679.40-8.912.79-9.422.9745.1568.50-85.8811.4713.54--0.015632.07-26.5411.23-86.25--34.36--
Shanghai General Hthy Info & Tech Co Ltd393.61m8.92m2.96bn355.00337.742.74--7.510.06440.06442.897.940.26013.050.77351,108,747.000.69087.980.968110.0029.1550.082.6626.001.824.300.135715.973.511.18-45.80-18.767.19--
Jinan High-tech Development Co Ltd324.74m-841.90m3.00bn565.00--68.36--9.23-1.03-1.030.37480.04960.1420.41550.8567574,762.40-39.48-8.01-161.56-27.2416.8228.09-277.95-31.770.8954--0.283---48.02-26.91-747.31---48.67--
Allgens Medical Technology Co Ltd213.78m-3.61m3.04bn271.00--2.12--14.22-0.0374-0.03741.5410.470.1381.192.90788,855.10-0.36995.24-0.38825.6164.9181.42-2.6830.3116.62--0.0296.47-9.034.09-123.35---29.51--
Kontour XiAn Medical Technology Co Ltd332.92m88.40m3.14bn311.0035.494.56--9.421.091.094.108.470.43562.7338.351,070,470.0011.4513.8212.9715.7277.1379.1826.2930.374.518.000.059528.5817.0616.8517.0711.2237.93--
Chemclin Diagnostics Co Ltd353.33m56.49m3.15bn629.0055.872.24--8.920.14070.14070.87993.510.19571.0616.07561,724.903.139.463.4410.5766.3673.9815.9930.726.62--0.147244.55-2.03-0.8218-13.77-2.0014.24--
Data as of Feb 06 2026. Currency figures normalised to Guangzhou Jet Bio-Filtration Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.11%Per cent of shares held by top holders
HolderShares% Held
Harvest Fund Management Co., Ltd.as of 30 Jun 20252.35m3.14%
China Asset Management Co., Ltd.as of 30 Jun 2025864.13k1.16%
Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025698.93k0.93%
Lion Fund Management Co., Ltd.as of 30 Jun 2025680.60k0.91%
GF Fund Management Co., Ltd.as of 30 Jun 2025366.44k0.49%
Guotai Asset Management Co., Ltd.as of 30 Jun 2025332.25k0.44%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025272.03k0.36%
CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025213.53k0.29%
Hui'an Fund Management Co. Ltd.as of 30 Jun 2025156.67k0.21%
China Southern Asset Management Co., Ltd.as of 30 Jun 2025136.40k0.18%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.